Optimization of the rapid carbapenem inactivation method for use with AmpC hyperproducers-authors' response
J Antimicrob Chemother
.
2022 Mar 31;77(4):1210-1211.
doi: 10.1093/jac/dkac058.
Authors
Mădălina Maria Muntean
1
2
3
,
Andrei-Alexandru Muntean
1
2
3
,
François Guerin
4
5
,
Vincent Cattoir
4
5
6
,
Elodie Creton
1
7
8
9
,
Garance Cotellon
1
7
8
9
,
Saoussen Oueslati
1
7
8
9
,
Mircea Ioan Popa
2
3
,
Delphine Girlich
1
8
9
,
Bogdan I Iorga
10
,
Rémy A Bonnin
1
8
9
,
Thierry Naas
1
7
8
9
Affiliations
1
TeamRESIST, INSERM U1184, School of Medicine, Université Paris-Saclay, LabEx LERMIT, Le Kremlin-Bicêtre, France.
2
The "Carol Davila" University of Medicine and Pharmacy, Bucharest, Romania.
3
The "Cantacuzino" National Medico-Military Institute for Research and Development, Bucharest, Romania.
4
CHU de Rennes, Service de Bactériologie-Hygiène Hospitalière, Rennes, France.
5
CNR de la Résistance aux Antibiotiques ("laboratoire associé Entérocoques"), Rennes, France.
6
Université de Rennes 1, Inserm U1230, Rennes, France.
7
Bacteriology-Hygiene unit, Assistance Publique/Hôpitaux de Paris, Bicêtre Hospital, Le Kremlin-Bicêtre, France.
8
French National Reference Center for Antibiotic Resistance: Carbapenemase-resistant Enterobacterales, Le Kremlin-Bicêtre, France.
9
Joint research Unit EERA "Evolution and Ecology of Resistance to Antibiotics", Institut Pasteur-APHP-Université Paris Sud, Paris, France.
10
Université Paris-Saclay, CNRS, Institut de Chimie des Substances Naturelles, Gif-sur-Yvette, France.
PMID:
35199171
DOI:
10.1093/jac/dkac058
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents / therapeutic use
Bacterial Proteins
Carbapenems* / pharmacology
Microbial Sensitivity Tests
beta-Lactamases*
Substances
Anti-Bacterial Agents
Bacterial Proteins
Carbapenems
beta-Lactamases